Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
107,3 USD | +1,91% | -1,68% | -2,53% |
19/04 | ABBOTT LABORATORIES : Een koopadvies van UBS | ZM |
18/04 | ABBOTT LABORATORIES : RBC Capital Markets handhaaft koopadvies | ZM |
Officiële publicaties
SEC Filing 8K | CO | |
1st quarter results | CO | |
SEC Filing 10K | CO | |
SEC Filing 8K | CO | |
SEC Filing 13G | CO | |
SEC Filing 8K | CO | |
Annual results | CO | |
Dividends | CO | |
SEC Filing 10Q-3 | CO | |
3rd quarter results | CO | |
SEC Filing 8K | CO | |
SEC Filing 10Q-2 | CO | |
1st-half-year results | CO | |
SEC Filing 8K | CO | |
SEC Filing 10Q-1 | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO |
- Beurs
- Aandelen
- Koers ABT
- Nieuws Abbott Laboratories
- Officiële publicaties